Will the stigma around ECT fade? Will ECT simply grow less relevant in the age of ketamine and MST? What’s the future of neuromodulation?
Join Dr. David Gratzer as he speaks to Dr. Daniel Blumberger, scientific director of the Temerty Centre for Therapeutic Brain Intervention and professor at the University of Toronto to find out.

During their discussion, we learn about:

• the 20-30 active clinical trials at the Temerty Centre
• the impact and efficacy of some of the newer treatments like ketamine, rTMS, and MST
• the latest in the literature on ECT and suicide prevention
• and that ECT isn’t being replaced any time soon.

THANKS FOR LISTENING!

Quick Takes is a production of the Center for Addiction and Mental Health. You can find links to the relevant content mentioned in the show and accessible transcripts of all the episodes we produce online at CAMH.ca and on the CAMH Global Learning Academy.

Follow CAMH Education on X (formerly known as Twitter) @camhEdu

Follow and subscribe to Reading of the Week where, every week, Dr. David Gratzer reviews research papers from the world of psychiatry.